News
-
Visana Health Secures $10.1M for Virtual Women’s Health Platform
Visana Health’s seed funding was led by Flare Capital Partners and Frist Cressey Ventures and included participation from InHealth Ventures, Oxeon Partners, Pixel Perfect Ventures and Venture Investors. In total, the company has raised more than $13 million.
-
Nurse Practitioners’ Starting Salaries Are Rising Faster Than Those of Primary Care Physicians
As retail disruptors like CVS, Walgreens and Amazon buy more and more primary care assets, the healthcare industry is seeing an increased demand for physicians and advanced practitioners. In the case of nurse practitioners, this rise in demand is also boosting their salaries. Physicians’ starting salaries have remained relatively flat, but their average signing bonus grew.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Nurses’ Mental Health Is Improving, But It’s Still Far From Where It Needs to Be
A recent survey on nurses’ mental health offers some reasons for cautious optimism. The survey showed that nurses’ mental health has continued to improve since its bleakest days during the peak of the pandemic. However, most nurses said they remain unhappy with their employer’s efforts to prioritize their mental wellbeing.
-
Hey Jane Expands Virtual Services Beyond Abortion Care into Reproductive, Sexual Health
New York City-based Hey Jane, a virtual abortion provider, announced last week that it is now offering vaginal infections treatment. This includes treatment for urinary tract infections, bacterial vaginosis and herpes. It is also offering birth control and emergency contraception.
-
Consumer / Employer, Health Tech
Amazon’s Automatic Coupons for Diabetes Products While “Incremental” Will Still Be a “Gamechanger,” Experts Say
Amazon Pharmacy announced Tuesday that it is launching automatic coupons for more than 15 insulin and diabetes care brands. The move, while incremental, solves a major pain point for consumers with diabetes, as many struggle to afford insulin products.
-
Artificial Intelligence, Health IT, Health Tech, Startups
Epic Is Integrating Abridge’s Generative AI Tool Into Its EHR
Epic announced that it will integrate Abridge’s clinical documentation tool into its EHR workflow. The startup’s generative AI tool listens to visits and creates a near-instant summary that adheres to physicians’ prototypical note structure.
-
Precision Bio Offloads Lead Cell Therapy Program in Pivot to In Vivo Gene Editing
Imugene gains global rights to Precision BioSciences’ most advanced program, an allogeneic cell therapy for advanced cases of blood cancer. Precision will now focus on in vivo gene editing therapies, some of which is partnered with Novartis and Eli Lilly.
-
Gilead Partners With Startup Getting Its Tentacles Into New Biologic Drug Territory
Gilead Sciences is partnering with Tentarix Biotherapeutics, a startup developing multifunctional antibody drugs that it calls “Tentacles.” Tentarix’s technology offers the potential to selectively address targets in cancer and inflammation.
-
MedArrive, Heartbeat Health Team Up To Offer In-home Cardio Care
In-home provider MedArrive can now connect members of its payer customers, particularly Medicaid plans, to Heartbeat Health for virtual cardiovascular services, the companies announced Tuesday.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Pfizer Expands to Multiple Myeloma With FDA Approval for New Antibody Drug
Oncology is already a big piece of Pfizer’s drug lineup. The portfolio is expanding to multiple myeloma with FDA approval of Elrexfio, a bispecific antibody that targets the cancer protein BCMA.
-
MedCity Influencers, BioPharma
Fine-Tuning, Prompt Engineering are Keys to Delivering Real Generative AI Solutions to Commercial Pharma Operations Today
Generative AI further enhances the value of prompt engineering by synthesizing important insights from various interactions, including text, images, compliant transcripts, and call notes. By automating this process, generative AI quickly transforms on-the-ground insights into robust analytics.
-
Who is Supporting Family Caregivers?
The role of the family caregiver is considered part of the cycle of life. But it can be time consuming and stressful, especially if caregivers have to balance their role with a job, raising children, and other aspects of family life. The topic will be one of many discussed at the HLTH event in Las Vegas from October 8-11.
-
Harmony Bio’s Zynerba Buyout Brings Cannabinoid That Doesn’t Spark Euphoria
Zynerba Pharmaceuticals’ lead drug candidate is designed to bring the therapeutic effect of cannabinoids without also causing euphoric effects. The synthetic cannabinoid in a topical gel formulation includes none of the psychoactive compounds from the cannabis plant.
-
Maintaining the Right To Work as Independent Nursing Professionals Is a Fight for Equality
Staffing agencies are convincing hospitals that it is dangerous to hire nurses like me, telling them that us independent nurses are not equipped to provide quality patient care, and that hiring independent nurses could open the door for legal ramifications.
-
MedCity Influencers, Health Tech
4 New Femtech Innovations Demystifying and Normalizing Menstruation
FemTech is at the forefront of providing effective solutions to menstrual challenges, and the efforts to normalize and destigmatize menstruation are paving the way for the democratization of women’s healthcare.
-
Consumer / Employer, Health Tech
New App Aims To Support Teens with Sickle Cell Disease
HPC International launched Pinpoint, an app that helps teens manage their sickle cell disease. It allows them to learn about the disease, track their pain and communicate with their physicians.
-
FDA Approves J&J Combo Drug for Prostate Cancers With Certain Genetic Signature
Johnson & Johnson’s Akeega is approved for treating advanced prostate cancer with a BRCA mutation. The drug, which interferes with a way cancer cells repair themselves, will compete against recently approved drugs from Pfizer and partners AstraZeneca and Merck.
-
What Providers Need to Know About Fighting the Nursing Shortage Through Tech
A new Accenture report laid out considerations that hospitals should keep in mind as they adopt new technology aimed at improving nurse retention. Some of the report’s key recommendations for providers were to build a strong, cloud-based technology infrastructure and to involve nurses early on in the process of adopting a new digital tool.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
